Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Sponsors seek $35 insulin cap, $100 cap for devices in Insulin Reduction Act
Summary
Sponsors of House Bill 263 told the Health Committee the bill would cap insulin cost‑sharing at $35 and add a $100 cap for diabetes devices; sponsors cited Ohio Department of Health and American Diabetes Association figures and pledged to provide supporting studies and a list of states with similar caps.
House Bill 263, the Insulin Reduction Act, received sponsor testimony and questions during a first hearing before the Ohio House Health Committee. A sponsor said the bill would cap cost‑sharing for insulin at $35 per prescription and create a $100 limit for diabetes care devices such as glucose monitors and insulin pumps. The…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
